Eli Lilly & Co. (LLY) Tops Q4 EPS by 21c, Updates FY Guidance

Go back to Eli Lilly & Co. (LLY) Tops Q4 EPS by 21c, Updates FY Guidance

Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition

January 30, 2020 6:25 AM EST

INDIANAPOLIS, Jan. 30, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced financial results for the fourth quarter and full year of... More